Skip to main content

OPHI · CollPlant Biotechnologies Ltd · Documents

Track OPHI — free
$3.65 At close · Nov 13 Q3 2024 earnings call transcript
Market Cap
$11.23M
Shares
3.08M
Volume · Nov 13 387.75K Avg daily vol (1 sessions) 387.75K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $2.37M up 360.4% 20-F filed Mar 26, 2026 Earnings call Q3 2024 earnings call Held Sep 30, 2024
2026
Nov 12
Current report 6-K
Shares Begin Trading on Nasdaq Under OPHI

CollPlant Biotechnologies Ltd. said its ordinary shares will begin trading on Nasdaq as “OPHI” at the open on November 13, 2026, after closing under “CLGN” on November 12, 2026; no shareholder action is required.

2 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) (“CollPlant”) today announced that its ordinary shares will begin trading on Nasdaq under the new ticker symbol “OPHI,” effective at the open of trading on November 13, 2026. The shares will continue to trade under “CLGN” through the close of trading on November 12, 2026. No action is required by shareholders in connection with the ticker symbol change. Open the document at this passage
Nov 12
Current report 6-K
LightSolver to debut all-optical computer at SC26

CollPlant Biotechnologies Ltd. subsidiary LightSolver will publicly demonstrate its all-optical Laser Processing Unit at SC26 in Chicago November 16-19, 2026, solving linear equations, differential equations and complex optimization problems, alongside Boeing corrosion-simulation benchmarks.

3 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd. (“LightSolver”), a pioneer of pure photonic computing and developer of the Laser Processing Unit (LPU)™, will unveil the LPU capabilities in a first public demonstration at SC26, the International Conference for High Performance Computing, taking place November 15-20, 2026 in Chicago. The demonstration will be presented at LightSolver’s booth #5102 during the exhibition, November 16-19. In this first public demonstration of an all-optical computer, LightSolver will showcase live how the LPU solves real mathematical and computational problems – including systems of linear equations, differential equations, and complex optimization problems – using only interacting light. LightSolver will present its work with Boeing on PDE-based corrosion simulation at the SC26 Exhibitor Forum. Open the document at this passage
Nov 5
Current report 6-K
IIA Approves Grant for LightSolver LPU Development

CollPlant Biotechnologies Ltd. said the Israel Innovation Authority approved an approximately $1.8 million grant for subsidiary LightSolver Ltd. to advance its Laser Processing Unit (LPU) development; receipt remains subject to the authority’s customary terms.

2 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that the Israel Innovation Authority (IIA) has approved a grant of approximately $1.8 million to its subsidiary, LightSolver Ltd. (“LightSolver”), to support the continued development of its Laser Processing Unit (LPU), an all-optical, laser-based computing platform. The grant is subject to the IIA’s customary terms. Open the document at this passage
Nov 4
Current report 6-K
Proposed Rebrand Reflects Expansion Into Computing With Light

CollPlant Biotechnologies Ltd. proposed changing its name to OptiPhi Computing Ltd. and Nasdaq ticker from “CLGN” to “OPHI,” reflecting expansion into photonic computing after acquiring LightSolver Ltd. in September 2026; shareholder approval is required.

2 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its Board of Directors has approved a proposal to change the Company’s name to OptiPhi Computing Ltd., subject to shareholders approval and completion of the applicable corporate and regulatory procedures. The proposed name reflects the Company’s focus on computing with light following its acquisition of LightSolver Ltd. (“LightSolver”) in September 2026. In connection with the proposed change, the Company also intends to change its Nasdaq trading symbol from “CLGN” to “OPHI”, subject to Nasdaq confirmation and completion of the applicable process. Open the document at this passage
Nov 2
Current report 6-K
Current report

CollPlant Biotechnologies Ltd. appointed Eran Rotem CEO effective November 2, 2026, replacing Yehiel Tal, as part of a cost-reduction plan. The company is discontinuing regenerative medicine research and development but plans to continue rhCollagen production and supply.

Oct 29
Current report 6-K
Current report

CollPlant Biotechnologies Ltd. subsidiary LightSolver signed an agreement with the Directorate of Defense Research & Development within the Israel Ministry of Defense to develop and deliver an LPU, establishing a multi-year framework with an initial order covering the first 12 months.

Oct 15
Current report 6-K
Current report

CollPlant Biotechnologies Ltd. closed a private placement on October 14, 2026, raising approximately $3.7 million gross through 989,301 ordinary shares or pre-funded warrants and warrants for up to 1,483,950 ordinary shares at $3.74 per share.

Read from the first part of this long document
Oct 9
Current report 6-K
Current report

CollPlant Biotechnologies Ltd. entered agreements for a private placement of 989,301 ordinary shares and warrants for up to 1,483,952 ordinary shares at $3.74 per share, expected to raise approximately $3.7 million and close on or about October 14, 2026.

Sep 30
Current report 6-K
Current report

CollPlant completed its LightSolver acquisition on September 3, 2026. For the six months ended June 30, 2026, revenue was $181,000, net loss was $5.8 million, cash was $2.6 million, and management reported substantial doubt about continuing as a going concern.

Read from the first part of this long document
Sep 24
Current report 6-K
Current report

On September 24, 2026, CollPlant Biotechnologies Ltd. announced peer-reviewed LightSolver and High-Performance Computing Center Stuttgart research projecting LightSolver LPU time-to-solution acceleration of approximately 40× to more than 80,000× versus GPU algorithms on sparse linear systems.

Sep 22
Current report 6-K
Current report

CollPlant Biotechnologies Ltd. regained Nasdaq compliance with Listing Rule 5550(a)(2), requiring a $1.00 per share minimum bid price; Nasdaq closed the matter after the price met the threshold from September 4, 2026 to September 18, 2026.

Mar 26
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $2.37M ▲ 360.4% Net loss $11.49M Diluted EPS -$0.94
2025
Showing 1–50 of 157 documents
Key facts CIK 1631487 13F (30d) 7 filings 7 filers Visit website Investor relations